Last updated on December 2018

Tolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Patients With Dementia-Related Psychosis and/or Agitation and Aggression


Brief description of study

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

 

Clinical Study Identifier: TX217344

Find a site near you

Start Over